Posted on Monday, November 17, 2025
|
by AMAC Newsline
|
0 Comments
|
Senior Americans have long faced tough choices when it comes to their health care. From rising costs to confusing coverage, it’s no surprise that many seniors express deep frustration with Big Pharma. When Health and Human Services Secretary Kennedy recently proposed new restrictions on pharmaceutical advertisements, many expected seniors to strongly support the move.
But AMAC’s new survey reveals a more nuanced reality. Seniors want to strike a balance between sensible requirements ensuring integrity in pharmaceutical ads while also avoiding overregulation and piles of red tape that stifle innovation, drive costs even higher, and make it more difficult for patients to access products that could improve their lives.
A Divided View on Big Pharma and Ads
According to AMAC’s findings, most respondents (60%) hold an unfavorable opinion of pharmaceutical companies. Yet more than half (53%) said they oppose any outright ban on televised drug advertisements. The Trump administration has emphasized that a ban is not on the table, but HHS’s proposed rollback to pre-1997 standards could make TV ads so long and complicated that they become economically unfeasible—a move many seniors see as a de facto ban.
Do Ads Sway Consumers?
HHS officials argue that drug ads give pharmaceutical companies too much influence, shaping consumer expectations with overly positive messaging. The survey found that seniors partially agree: 58% said these ads have a great deal or fair amount of influence, and more than one in four (27%) said an ad had prompted them to ask their doctor about a medication.
Even so, older Americans are confident in their physicians’ ability to make sound medical decisions. Seven in ten said they trust their doctors not to prescribe a medication that would be unsafe or unnecessary, even if it had been heavily advertised. Only 12% thought their doctor might prescribe it anyway. That’s an important reminder that seniors still rely on—and respect—the professional judgment of their health care providers.
The Positive Side of Advertising
Interestingly, many seniors see a potential benefit in pharmaceutical advertising. Nearly two-thirds (62%) said they appreciate how drug ads help raise awareness about mental health issues—an area where open discussion has often been limited. In that sense, advertising can play a positive social role by encouraging conversations about sensitive health conditions and prompting individuals to seek help.
AMAC’s survey also found that seniors tend to trust the ads they see on television more than those on social media. Hearing about potential side effects actually increased trust for many respondents, suggesting that clear disclosure fosters confidence in the information being shared.
The Demand for Full Information
Seniors overwhelmingly expressed a desire for access to complete and direct health information. About two-thirds (65%) said they prefer to see all the available facts about new medications rather than rely solely on their doctor’s summary. Yet when it comes to the federal government as a source of information, confidence is low—64% said they have little or no trust in government-provided medical guidance, a lingering effect of the COVID-19 response missteps.
Protecting Free Expression
The survey also highlights concerns about misinformation and government overreach. Nearly three-quarters (73%) said they oppose government control over which ads the public can see. Two-thirds worried that such authority could easily be politicized or misused. Seniors—many of whom have lived through decades of shifting government policies—remain wary of any attempt to regulate speech under the banner of public health.
Finding the Right Balance
President Trump’s “Make America Healthy Again” initiative aims to strengthen consumer protections while promoting transparency between patients, doctors, and industry. Those goals have broad support among older Americans. But as Washington weighs new restrictions on advertising, policymakers should take careful note of what seniors are saying.
Americans do not want limits on what they can learn about their own health care. Seniors want accuracy, clarity, and accountability—but not censorship. As they see it, a well-informed public remains the best defense against abuse, whether from corporations or bureaucrats.
That’s a principle worth remembering as Washington policymakers shape the future of pharmaceutical advertising in America.
Read the full article here